A PILOT STUDY OF NEOADJUVANT ENDOCRINE THERAPY TOLERANCE TO INFORM TREATMENT DECISIONS FOR ADJUVANT RADIATION IN GERIATRIC, EARLY STAGE ER+ BREAST CANCER

IRB/UVA Tracking #
22040
Contact
Sarah T Lewis
Contact Email
Contact Phone
Phase
NA
Primary purpose
Treatment
Cancer PI
Trish Millard
Status
OPEN TO ACCRUAL
Ages
Adult